Global Antifungal Agents (Drugs, Therapies, and Applications) Market is anticipated to grow at a CAGR of 3.70%
A new market research report publishes by Inkwood Research, indicates that the global antifungal agents (drugs, therapies, and applications) market are expected to grow at a CAGR of 3.70% between 2017 and 2025.
Browse 41 market data tables and 55 figures spread through 260 pages and in-depth TOC on “Global Antifungal Agents (Drugs, Therapies, and Applications) Market Forecast 2017-2025”
The antifungal agents (drugs, therapies, and applications) market would be growing at a high rate in near future due to increase in awareness among people regarding various fungal infections etc. The major drivers for the antifungal agents market are poor hygiene habits, development of drug resistance, healthcare policies and various hygiene awareness programs by the government. The various market opportunities available in the market include healthcare and related industries are which are always growing continuously due to increasing awareness of hygiene-related diseases.
Learn more about this report, request a free sample copy of Antifungal Agents
Systemic Azoles lead the anti-fungal agents market by Drug types market
The antifungal agents market can be segmented into three types- Drugs, therapeutic indications, and applications. Drugs include Systemic azoles, Topical azoles, Systemic polyenes, Topical polyenes, Systemic Echinocandins, Systemic antimetabolites, other systemic, other topical and other drugs types. Systemic azoles hold the largest market share in 2017 and Systemic echinocandins are anticipated to grow at a CAGR of 4.09% during the forecast period.
Aspergillosis holds the largest market share in terms of Therapeutic Indications
Therapeutic indications consist of aspergillosis, dermatophytosis, candidiasis, and others. The candidiasis market is anticipated to grow at a faster rate. Aspergillosis refers to an infection that is caused by Aspergillus i.e. a type of fungus. Such kind of fungus is often found in stored grain, dead leaves, and compost piles or in other decaying vegetation.
Oral antifungal drugs market presumed to grow rapidly in terms of Application during the forecast period
The antifungal agent's application market is segregated into topical antifungal agents and oral drugs. Topical drugs include medicines which can be applied to the area affected or directly. To give fast results as they are first absorbed through the skin and then circulated. The oral drugs market is anticipated to grow at a faster rate between 2017 and 2025. Oral antifungal drugs include terbinafine, fluconazole, itraconazole, and ketoconazole. These oral antifungal drugs are reserved for severe infections when the topical drugs are ineffective. These medicines may be used to treat athlete’s foot or fungal nail infections. Most of the oral drugs are only available through prescription and can be taken as dosage in forms of capsules, tablets, and suspensions.
North America dominating, the Asia Pacific picking up the pace
Global antifungal agents market can be geographically segmented into Asia-Pacific, North America, Europe, and the Middle East. North America is the dominant player in this market. It captures largest market share owing to its advancing incidence of fungal infections and the development of novel antifungal biopharmaceuticals. The reason behind the growth in this region is huge investments made in drug productions. The government initiatives also play a key role. Asia-Pacific is another region where the antifungal market is growing at a good speed. Due to developing countries like India, China these countries are highly populated so there is an increase in awareness among the people. Europe’s market is expected to grow due to high advantages of its diversity.
The key players in this market are Bayer healthcare, Teva Pharmaceuticals, Gilead, GlaxoSmithKline, Johnson & Johnson, Kramer laboratories, Merck & co., Novartis, Pfizer, Abbott Laboratories, Arbor Pharmaceuticals Inc., 3 Baxter, Sanofi-Aventis, vertex pharmaceuticals. Major companies involved in this market are Astellas Pharma Inc., Johnson & Johnson, Teva Pharma, Novartis, and Pfizer. Astellas Pharma is the biggest in terms of production and market capitalization. The growth in the healthcare industry from last few years supported by government initiatives has created significant growth opportunities for the antifungal agents market.
The anti-fungal agent market report provides competitive landscapes, market drivers, trends, restraints, opportunities and challenges in this market. The report estimates the current size and the future growth potential of the market across diverse applications, technologies, verticals, types, and regions. The outlook of the report additionally comprises of mergers and acquisitions, strategies, product portfolios, agreements, partnerships and collaborations amongst the key players.
About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals including technology, automotive, chemicals, materials, healthcare, and energy with objective comprehension acknowledging the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.
CONTACT US
+1 857-302-4704
Comments
Post a Comment